| Literature DB >> 27769168 |
Pierre Dehoux1, Jean Christophe Marvaud2, Amr Abouelleil3, Ashlee M Earl3, Thierry Lambert2,4, Catherine Dauga5,6.
Abstract
BACKGROUND: Clostridium bolteae and Clostridium clostridioforme, previously included in the complex C. clostridioforme in the group Clostridium XIVa, remain difficult to distinguish by phenotypic methods. These bacteria, prevailing in the human intestinal microbiota, are opportunistic pathogens with various drug susceptibility patterns. In order to better characterize the two species and to obtain information on their antibiotic resistance genes, we analyzed the genomes of six strains of C. bolteae and six strains of C. clostridioforme, isolated from human infection.Entities:
Keywords: Antimicrobial resistance; Butyrate pathway; Clostridium bolteae; Clostridium clostridioforme; Comparative genomics
Mesh:
Substances:
Year: 2016 PMID: 27769168 PMCID: PMC5073890 DOI: 10.1186/s12864-016-3152-x
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Sequencing statistics and genome information
| Strain name | Year of isolation | Origin | CIP | Average sequencing coverage (times) | No. of contigs | Genome size (kb) | Predicted no. of genes (Broad Institute) | Predicted no. of proteins (Broad Institute) | No. of strain-specific CDSs (singletons & paralogs) | No. of strain-specific CDSs (unique) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| 90A5 | 2009 | perineal abcess | 110254 | 176 | 12 | 6394 | 5833 | 5716 | 84 | 73 |
|
| 90A7 | 2009 | intraabdominal fluid | 110239 | 185 | 8 | 6159 | 5719 | 5592 | 743 | 735 |
|
| 90A9 | 2009 | douglas abcess | 110242 | 134 | 1 | 6367 | 5833 | 5731 | 163 | 161 |
|
| 90B3 | 2009 | pelvis abcess | 110247 | 176 | 4 | 6480 | 6059 | 5949 | 239 | 188 |
|
| 90B7 | 2010 | pleural abcess | 110255 | 165 | 19 | 6398 | 5876 | 5761 | 120 | 105 |
|
| 90B8 | 2010 | ureteral abcess | 110256 | 76 | 21 | 6449 | 6023 | 5901 | 905 | 846 |
|
| 90A1 | 2009 | intraabdominal fluid | 110245 | 145 | 16 | 5769 | 5669 | 5546 | 130 | 72 |
|
| 90A3 | 2009 | sigmoid abcess | 110246 | 135 | 11 | 5467 | 5231 | 5096 | 31 | 21 |
|
| 90A4 | 2009 | bone biopsy | 110238 | 264 | 48 | 5820 | 5726 | 5547 | 97 | 72 |
|
| 90A6 | 2009 | intraabdominal fluid | 110240 | 167 | 22 | 5970 | 5851 | 5711 | 307 | 273 |
|
| 90A8 | 2009 | intraabdominal fluid | 110249 | 82 | 47 | 5927 | 5916 | 5734 | 1190 | 1006 |
|
| 90B1 | 2009 | rectal abcess | 110244 | 174 | 10 | 5533 | 5308 | 5184 | 48 | 36 |
Functional profile ( COG categories ) of C. bolteae and C. clostridioforme
| Core genome of | Core genome of | Shared between the two species | Specific of | Specific of | |
|---|---|---|---|---|---|
| Total Number of Orthologs groups | 3714 | 3660 | 2409 | 1305 | 1251 |
| Ortholog groups in COGs | 3060 | 2861 | 2151 | 909 | 710 |
| No Hits on COGs | 660 | 805 | 264 | 396 | 541 |
| INFORMATION STORAGE AND PROCESSING | |||||
| Translation, ribosomal structure and biogenesis (J) | 151 | 148 | 137 | 14 | 11 |
| Transcription (K) | 309 | 290 | 191 | 118 | 99 |
| Replication, recombination and repair (L) | 111 | 135 | 85 | 26 | 50 |
| CELLULAR PROCESSES AND SIGNALING | |||||
| Cell cycle control, cell division, chromosome partitioning (D) | 43 | 43 | 36 | 7 | 7 |
| Defense mechanisms (V) | 84 | 72 | 52 | 32 | 20 |
| Signal transduction mechanisms (T) | 180 | 139 | 101 | 79 | 38 |
| Cell wall/membrane/envelope biogenesis (M) | 122 | 137 | 97 | 25 | 40 |
| Cell motility (Cell motility and secretion) (N) | 34 | 18 | 0 | 34 | 18 |
| Intracellular trafficking, secretion, and vesicular transport (U) | 12 | 17 | 9 | 3 | 8 |
| Posttranslational modification, protein turnover, chaperones (O) | 84 | 83 | 72 | 12 | 11 |
| METABOLISM | |||||
| Energy production and conversion (C) | 194 | 155 | 120 | 74 | 35 |
| Carbohydrate transport and metabolism (G) | 431 | 425 | 296 | 135 | 129 |
| Amino acid transport and metabolism (E) | 335 | 276 | 238 | 97 | 38 |
| Nucleotide transport and metabolism (F) | 115 | 94 | 85 | 30 | 9 |
| Coenzyme transport and metabolism (H) | 99 | 89 | 72 | 27 | 17 |
| Lipid transport and metabolism (I) | 50 | 60 | 42 | 8 | 18 |
| Inorganic ion transport and metabolism (P) | 122 | 129 | 94 | 28 | 35 |
| Secondary metabolites biosynthesis, transport and catabolism (Q) | 12 | 0 | 0 | 12 | 0 |
| POORLY CHARACTERIZED | |||||
| General function prediction only (R) | 366 | 331 | 256 | 110 | 75 |
| Function unknown (S) | 187 | 178 | 150 | 37 | 28 |
Fig. 1Distance-based phylogenetic tree of flagellin genes. Values at nodes corresponded to bootstrap percents obtained from phylogenetic trees based on multiple sequence alignments by ClustalW, Tcoffee or Promals, respectively. Gene names and, orphan or cluster numbers were indicated
Fig. 2Different pathways for butyrate synthesis potentially present in genomes of C. clostridioforme and C. bolteae. In solid lines : found in C. bolteae and C. clostridioforme; In bold dashed lines : only found in C. clostridioforme ; In fine dashed lines : only found in C. bolteae 90A5 and 90B7 (for more details, see Additional file 4: Table S4). Genes (protein names) are displayed. Ato, Acetyl-CoA acetyltransferase ; Bcd, butyryl-CoA deshydrogenase ; Buk, butyrate kinase; But, Butyrate-acetoacetate CoA-transferase ; Cro, crotonase ; Etf, electron transfer protein ; Gcd, glutaconyl-CoA decarboxylase ; Hbd, Acetoacetyl-CoA reductase ; 4Hbt, 4-hydroxybutyrate CoA transferase ; HgCoAd, 3-hydroxybutyryl-CoA dehydrogenase ; Ptb, phosphate butyryltranferase; Thl, thiolase
Distribution of CDSs annotated as antimicrobial resistance genes
| ARDB | Number of clusters and orphans |
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| class A beta-lactamase | blaCLO1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| class B beta-lactamase | metallo-enzymes | 4 | 1 | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 1 |
| class C beta-lactamase | Amp C and Penicillin Binding Protein | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| class D beta-lactamase | Amp D (oxa type) | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Teicoplanin, Vancomycin | VanRA | 4 | 2 | 1 | 1 | 1 | 1 | 3 | 1 | |||||
| VanSA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||
| VanD | 2 | 2 | 2 | 2 | 2 | 2 | ||||||||
| VanSD | 1 | 1 | 1 | 1 | 1 | 1 | ||||||||
| VanXD | 1 | 1 | 1 | 1 | 1 | 1 | ||||||||
| VanRD | 2 | 1 | 1 | 1 | 1 | 1 | ||||||||
| Vancomycin | VanHB | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| VanRB | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | |
| VanB | 1 | 1 | ||||||||||||
| VanSB | 1 | 1 | ||||||||||||
| VanWB | 1 | 1 | ||||||||||||
| VanXB | 1 | 1 | ||||||||||||
| VanYB | 2 | 2 | ||||||||||||
| VanSC | 1 | 1 | ||||||||||||
| VanRE | 1 | 1 | 1 | 1 | ||||||||||
| VanG | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| VanRG | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |
| VanYG | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||||
| VanUG | 3 | 2 | 1 | |||||||||||
| Teicoplanin | VanZ | 4 | 2 | 3 | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Lincomycin | LnuA | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 |
| Macrolides | ErmB | 1 | 1 | 1 | ||||||||||
| Macrolide-Lincosamide- Streptogramin (efflux pumps) | MacB | 1 | 6 | 8 | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 6 |
| MefA | 1 | 3 | 2 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | |
| MsrA/MsrB | 5 | 3 | 3 | 3 | 3 | 3 | ||||||||
| Lsa | 1 | 1 | 1 | 1 | ||||||||||
| ABC transporter (efflux pumps) | VgaA | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Tirc | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| CcmA | 6 | 2 | 2 | 3 | 3 | 2 | 4 | 3 | ||||||
| Streptogramin_A Chloramphenicol | VatB | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| chloramphenicol | CAT | 3 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | ||||
| linezolide | Cfr | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Rifampicin | Arr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Metronidazole | Nim | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Trimethoprim | Dfra20 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Dfra | 1 | 1 | ||||||||||||
| Aminoglycosides | Aac6ie | 2 | 2 | |||||||||||
| Aad9ib | 1 | 1 | ||||||||||||
| Ant6ia | 3 | 1 | 1 | 2 | 1 | 2 | 1 | |||||||
| Aph3iiia | 1 | 2 | 1 | 1 | ||||||||||
| Apha | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |
| Tetracycline | Tet40 | 1 | 1 | 1 | ||||||||||
| TetO | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| TetW | 1 | 1 | 1 | 1 | 1 | |||||||||
| Tet32 | 1 | 1 | 1 | |||||||||||
| Bacitracin | BacA | 3 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 2 |
| BcrA | 1 | 2 | 3 | 4 | 4 | 2 | 3 | 3 | 4 | 4 | 3 | 4 | 5 | |
| Multidrug resistance efflux pump | Blt | 1 | 1 | |||||||||||
| AcrB | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
aBroad annotation
Antibiogram of C. clostridioforme and C. bolteae
|
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antimicrobial agent | 90A5 | 90A7 | 90A9 | 90B3 | 90B7 | 90B8 | 90A1 | 90A3 | 90A4 | 90A6 | 90A8 | 90B1 |
| Beta - lactams | ||||||||||||
| ampicillin | R | R | R | R | R | R | R | R | R | R | R | R |
| amox-clavulanic acid | S | S | S | S | S | S | S | S | S | S | S | S |
| cefoxitin | S | S | S | S | S | S | S | R | S | I | S | I |
| imipenem | S | S | S | S | S | S | S | S | S | S | S | S |
| Glycopeptides | ||||||||||||
| Vancomycin | S | S | S | S | S | S | S | S | S | S | Ra | S |
| Macrolides | ||||||||||||
| Erythromycin | R | R | I | R | R | R | R | R | R | R | R | R |
| Telithromycin (Ketolides) | R | R | S | R | R | R | R | R | R | R | R | R |
| Spiramycin | S | S | S | R | S | I | S | S | R | R | R | S |
| Lincosamides | ||||||||||||
| Lincomycin | I | R | R | R | R | R | S | I | R | R | R | R |
| Clindamycin | S | S | S | R | S | S | S | S | R | S | R | S |
| Streptogramins | ||||||||||||
| Pristinamycin | S | S | S | nd | I | S | S | S | S | S | S | S |
| Amphenicols | ||||||||||||
| Chloramphenicol | nd | S | S | R | S | R | S | S | S | S | S | S |
| Oxazolidinones | ||||||||||||
| Linezolid | S | S | S | Rb | S | S | S | S | S | S | S | S |
| Rifampin | S | Rc | S | S | S | S | S | S | S | S | S | S |
| Quinolones | ||||||||||||
| Ciprofloxacin | R | R | R | R | R | R | R | R | R | R | R | R |
| Moxifloxacin | R | R | R | R | R | R | R | R | R | R | R | R |
| Tetracyclines | ||||||||||||
| Doxycycline | S | R | R | R | R | S | R | R | R | R | R | R |
| Nitroimidazole | ||||||||||||
| Metronidazole | S | S | S | S | S | S | S | S | S | S | S | S |
| Polypeptides | ||||||||||||
| Colistin | R | R | R | R | R | R | R | R | R | R | R | R |
aMIC vancomycin > 250 mg/l
bMIC linezolid =16 mg/l
cMIC rifampin =32 mg/l
Fig. 3Distribution of antibiotic resistance genes shared between and within the core of C. bolteae and C. clostridioforme. Genes overlapping at least 90 % length and 90 % of similarity were considered homologs. Resistance genes were predicted on a value up to 40 % identity (50 % of positive substitutions) on 70 % of length by homology sequence research on ARDB. For all C. clostridioforme and some C. bolteae 23S rRNA methyltransferase Cfr-like